Texas lands major pharma investment with $2.3 billion manufacturing project

Bristol Myers Squibb chooses Houston

A $2.3 billion pharmaceutical project is coming to Houston, bringing major investment to the city for years. Bristol Myers Squibb says its Generation Park campus will expand U.S. manufacturing and help produce next-generation medicines for patients across several disease areas.

The project adds a major name to Houston’s growing life sciences economy while creating skilled jobs and construction activity. BMS says the campus is designed for long-term growth, giving the company room to expand its workforce, capabilities, and production later.

Bristol Myers Squibb plans big campus

Bristol Myers Squibb plans to build an approximately 600,000-square-foot manufacturing campus at Generation Park. The company says the campus will use a modular design, allowing manufacturing capacity to be added or reconfigured as its pipeline and production needs change.

That flexible setup is intended to support changing technologies, products, and manufacturing needs over time. BMS says the campus is designed for long-term growth and can expand beyond its initial configuration.

Bristol Myers Squibb brings 500 jobs

Bristol Myers Squibb expects the Houston campus to employ nearly 500 people initially. Planned roles include operations technicians, production specialists, maintenance and engineering professionals, quality-control and quality-assurance experts, and employees in site leadership and administration.

BMS describes them as skilled, well-paying, long-term jobs across a range of career paths. The company also says the site’s workforce could grow as the campus expands in scale and capability.

2,000 more jobs could follow

The employment boost will extend beyond the permanent workforce at the finished campus. Bristol Myers Squibb expects approximately 2,000 construction and other indirect jobs between 2027 and 2030 as the Houston facility is built and brought online.

Those jobs are expected to support construction trades, engineering and technical service providers, logistics and distribution partners, local businesses, and suppliers connected to the project. BMS says the campus will generate economic activity beyond its direct workforce throughout the construction period.

One campus, several medicine types

The Houston campus is being designed to manufacture more than one type of medicine. Bristol Myers Squibb says its multi-modal capabilities will support small molecules, biologics, and antibody-drug conjugates across a range of disease areas.

The company says the site will support drug-product and finished-goods manufacturing from late development through launch. Its flexible design is intended to allow manufacturing capabilities to evolve as BMS’s pipeline and commercial needs change.

A factory designed to change

A modular design is central to the Houston plan. BMS says manufacturing capacity can be added or reconfigured as its pipeline, demand, and production priorities change.

The architecture is intended to allow new manufacturing capabilities to be brought online rapidly as pipeline and commercial needs evolve. BMS says the campus is designed to grow in scale and capability beyond its opening configuration.

Digital tools are built into the plan

Digital technology is also part of the campus plan. Bristol Myers Squibb says the Houston site will include advanced digital capabilities and a design that can adapt to future automation, helping the facility stay current as manufacturing systems continue evolving.

BMS says those tools are intended to support speed, quality, reliability, and a consistent supply of medicines across different production types. The company also expects digital integration to strengthen resilience, giving the campus more flexibility when needs or technology change.

Little-known fact: Pharmaceutical manufacturers are investing more in digital systems, automation, and data-driven tools to improve production monitoring and quality management.

Why did Houston win the project?

Houston and Generation Park were selected after Bristol Myers Squibb evaluated multiple markets in the Central and Eastern United States. The company cited the emerging strength of the local life-sciences workforce, available incentives, proximity to utilities and transportation infrastructure, and a business climate conducive to long-term growth.

Those factors are important for a large pharmaceutical manufacturing campus expected to operate and expand over many years. BMS says Houston and Texas offered the talent, infrastructure, and partnership needed to support the project.

Generation Park gets a pharma boost

The campus will be located at Generation Park, a 4,300-acre development in the Houston area. Bristol Myers Squibb describes the location as a hub for life sciences and advanced manufacturing, while Generation Park says the development is purpose-built to accommodate large-scale biomanufacturing and advanced manufacturing projects.

Generation Park also gives BMS room to build within a broader master-planned campus. The company points to workforce access, utilities, transportation infrastructure, and long-term growth potential as advantages of placing the manufacturing operation there.

Texas adds millions in incentives

Texas is supporting the project with financial incentives tied to jobs and investment. Governor Greg Abbott’s office says a $4.89 million Texas Enterprise Fund grant has been extended to Bristol Myers Squibb. TEF is a performance-based program available when a Texas site is competing with out-of-state locations.

The project is also qualified under the Texas Jobs, Energy, Technology, and Innovation program, or JETI. State officials say JETI is designed to attract large, capital-intensive projects that bring new investment and create good-paying jobs in Texas.

Little-known fact: Houston’s Texas Medical Center is one of the world’s largest medical complexes, bringing together hospitals, research institutions, universities, and healthcare organizations.

A piece of a $40 billion U.S. plan

The Houston project is part of a much larger Bristol Myers Squibb investment plan in the United States. BMS has committed $40 billion over five years to U.S. research and development, technology, and domestic manufacturing.

The company describes Houston as an important step in expanding its domestic manufacturing capabilities and supply resilience. The Texas campus will add U.S. manufacturing capacity while supporting BMS’s broader strategy for developing and producing future medicines.

BMS already had deep Texas ties

Bristol Myers Squibb already had connections to Texas before announcing the Houston campus. The company says it works with a contract manufacturer in the state for commercial and clinical trial production, giving BMS an existing manufacturing relationship in Texas today.

Its research presence is also substantial. BMS says it had 250 clinical trial sites across Texas in 2025, connecting the company with researchers, medical centers, and patients while the Houston project adds a much larger manufacturing footprint to the state.

Big energy projects can bring big changes, but they also raise important questions. Learn more about the Texas transmission plan and the concerns from lawmakers.

The project is built for the long run

Construction and related employment are expected to extend from 2027 through 2030 as the Houston campus is built and brought online. Bristol Myers Squibb says the site is designed to grow in scale and capability beyond its opening configuration.

That long-term flexibility is a central part of the project. BMS is planning for changing pipeline, commercial, digital, and manufacturing needs while Houston gains nearly 500 initial skilled jobs and a pharmaceutical manufacturing campus designed for future expansion.

The conversation around license plate cameras is growing quickly across Texas. Discover what’s driving the discussion and why residents are paying closer attention.

What do you think about Bristol Myers Squibb bringing a $2.3 billion pharmaceutical campus and hundreds of skilled jobs to Houston? Share your thoughts in the comments.

This slideshow was made with AI assistance and human editing.

Read More From This Brand:

• Mamdani renews calls to abolish ICE after fatal incident in Texas
• Emergency response choices draw attention in the Texas shooting case
• Texas election battle heats up as Hinojosa gains momentum against Abbott